Is DIZTF or MRK a better dividend investment in 2026?

DIZTF currently yields 895.66% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: DIZTF offers higher current income.

What is the dividend yield difference between DIZTF and MRK?

DIZTF has a forward dividend yield of 895.66% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 892.41 percentage points.

Home › Compare › DIZTF vs MRK

DIZTF vs MRK: Dividend Comparison 2026

DIZTF yields 895.66% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DIZTF wins by $7260963.48M in total portfolio value

INVESTMENT

TIME HORIZON10 years

DIZTF

● Live price

895.66%

Share price

$0.22

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$7260963.51M

Annual income

$5,953,403,020,932.87

Full DIZTF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — DIZTF vs MRK

📍 DIZTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DIZTF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DIZTF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DIZTF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DIZTF

Annual income on $10K today (after 15% tax)

$76,130.77/yr

After 10yr DRIP, annual income (after tax)

$5,060,392,567,792.94/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, DIZTF beats the other by $5,060,392,566,985.19/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DIZTF + MRK for your $10,000?

DIZTF: 50%MRK: 50%

100% MRK50/50100% DIZTF

Portfolio after 10yr

$3630481.77M

Annual income

$2,976,701,510,941.59/yr

Blended yield

81.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DIZTF

No analyst data

Altman Z

5.4

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DIZTF buys

MRK buys

No recent congressional trades found for DIZTF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDIZTFMRK

Forward yield	895.66% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$7260963.51M ✓	$30.7K
Annual income after 10y	$5,953,403,020,932.87 ✓	$950.29
Total dividends collected	$7159423.26M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DIZTF vs MRK ($10,000, DRIP)

Year	DIZTF Portfolio	DIZTF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$100,266	$89,565.61	$11,192	$351.54	+$89.1K → DIZTF
2	$946,569	$839,285.04	$12,524	$392.70	+$934.0K → DIZTF
3	$8,417,847	$7,405,017.75	$14,015	$438.65	+$8.40M → DIZTF
4	$70,551,839	$61,544,742.48	$15,682	$489.96	+$70.54M → DIZTF
5	$557,565,343	$482,074,875.60	$17,547	$547.23	+$557.55M → DIZTF
6	$4,157,153,660	$3,560,558,742.83	$19,632	$611.16	+$4157.13M → DIZTF
7	$29,258,606,851	$24,810,452,434.95	$21,963	$682.53	+$29258.58M → DIZTF
8	$194,502,319,400	$163,195,610,069.55	$24,571	$762.18	+$194502.29M → DIZTF
9	$1,222,019,145,437	$1,013,901,663,679.28	$27,486	$851.08	+$1222019.12M → DIZTF
10	$7,260,963,506,551	$5,953,403,020,932.87	$30,745	$950.29	+$7260963.48M → DIZTF

DIZTF vs MRK: Complete Analysis 2026

DIZTF — Stock

Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treatment of breast cancer. The company was incorporated in 2007 is headquartered in Lund, Sweden.

Full DIZTF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this DIZTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DIZTF vs SCHD DIZTF vs JEPI DIZTF vs O DIZTF vs KO DIZTF vs MAIN DIZTF vs JNJ DIZTF vs ABBV DIZTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.